Blueprint Medicines - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $88,797.98 +1.66%
Ethereum $2,969.30 +1.75%
BNB $841.81 +0.25%
Optimism $0.27 +2.03%
Arbitrum $0.19 +1.35%
Solana $123.63 +1.54%
Polygon $0.22 +2.77%
Cosmos $2.03 +1.71%
Avalanche $12.47 +1.92%

Bitcoin $88,797.98 +1.66%
Ethereum $2,969.30 +1.75%
BNB $841.81 +0.25%
Optimism $0.27 +2.03%
Arbitrum $0.19 +1.35%
Solana $123.63 +1.54%
Polygon $0.22 +2.77%
Cosmos $2.03 +1.71%
Avalanche $12.47 +1.92%

Blueprint Medicines

company

Investors

Number of Lead Investors

Number of Investors

4

15

Blueprint Medicines is funded by 15 investors. Partner Fund Management and Eight Roads Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Partner Fund Management	Yes	Series C
Eight Roads Ventures	Yes	Series Unknown
Casdin Capital	-	Series C
Cowen Group	-	Series C
Fidelity Biosciences	-	Series C
Nextech Invest	-	Series C
Perceptive Advisors	-	Series C
RA Capital Management	-	Series C
Redmile Group	-	Series C
Sabby Capital	-	Series C
Tavistock Life Sciences	-	Series C
Third Rock Ventures	-	Series C
Wellington Management	-	Series C
Biotechnology Value Fund	-	Series B
F-Prime Capital	-	Series B